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Polycystic ovarian syndrome with endometrial hyperplasia and uterine fibroids
treated with homoeopathy: A case report
Abstract
Introduction
Introduction: Any circumstance that alters the balance of oestrogen and progesterone leads to excessive,
prolonged estrogenic stimulation, or preventing the counteracting effects of progesterone causing
various pathological conditions in the reproductive system, as a result. Women with polycystic ovarian
syndrome (PCOS) have mostly anovulatory cycles and low serum progesterone levels. Endometrial
hyperplasia is most often due to excess oestrogen without progesterone. The clinical significance of
chronic oestrogen secretion is an increased risk of endometrial hyperplasia. A striking feature of uterine
fibroids (UFs) is their dependency on the ovarian oestrogen and progesterone. Existing treatments are
mostly directed at the symptoms but not at the syndrome itself.
Case Summary
Summary: A patient suffering from PCOS, with Endometrial Hyperplasia and multiple UFs, was
successfully treated with the homoeopathic medicine Pulsatilla nigricans. Repeat ultrasonography
showed normal endometrial thickness, no hyperechoic or hypoechoic lesions in uterus and no ovarian
PCOS morphology after treatment. Thus, the usefulness of homeopathic medicines for the treatment of
multi-morbid pathologies related to reproductive system of women is demonstrated.
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Abstract
Introduction: Any circumstance that alters the balance of oestrogen and progesterone leads to excessive, prolonged estrogenic stimulation,
or preventing the counteracting effects of progesterone causing various pathological conditions in the reproductive system, as a result. Women
with polycystic ovarian syndrome (PCOS) have mostly anovulatory cycles and low serum progesterone levels. Endometrial hyperplasia is most
often due to excess oestrogen without progesterone. The clinical significance of chronic oestrogen secretion is an increased risk of endometrial
hyperplasia. A striking feature of uterine fibroids (UFs) is their dependency on the ovarian oestrogen and progesterone. Existing treatments are
mostly directed at the symptoms but not at the syndrome itself. Case Summary: A patient suffering from PCOS, with Endometrial Hyperplasia
and multiple UFs, was successfully treated with the homoeopathic medicine Pulsatilla nigricans. Repeat ultrasonography showed normal
endometrial thickness, no hyperechoic or hypoechoic lesions in uterus and no ovarian PCOS morphology after treatment. Thus, the usefulness
of homeopathic medicines for the treatment of multi-morbid pathologies related to reproductive system of women is demonstrated.
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Introduction
Any alteration in the balance between oestrogen and
progesterone leading to excessive prolonged estrogenic
stimulation and preventing the counteracting effects of
progesterone causes various pathological conditions in
the reproductive system of women.[1] Various studies have
concluded that circulating androgens in the system are the
physiological regulators of the neuroendocrine mechanisms
governing ovulatory cyclicity. The pathophysiological
actions of androgens in females are also of key importance,
mainly as they relate to hyperandrogenic disorders in women.
Hyperandrogenaemia is a core characteristic of common
reproductive and metabolic disorders, such as polycystic
ovarian syndrome (PCOS). [1] A survey revealed that the
incidence of PCOS is quite alarming in women of reproductive
age in north India.[2]
Chronic anovulation, hyperandrogenism and/or the presence of
polycystic ovary morphology from ultrasound examination and
various degrees of gonadotropic and metabolic abnormalities
including vitamin D deficiency are associated with the
phenotypic manifestation of this disorder.[3,4]
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PCOS women have anovulatory menstrual cycles with low
serum progesterone levels.[5] There is a constant oestrogen
secretion with no cyclic pattern, leading to anovulatory cycles.
The clinical significance of chronic oestrogen secretions is
an increased risk of endometrial hyperplasia and probably
subsequent development of endometrial carcinoma.[6,7] PCOS
has other numerous long-term health risks too.[8]
Females with PCOS represent higher rates and severity of
depression and anxiety with reduced quality of life and an
increased prevalence of risk factors for cardiovascular disease
(CVD), such as hypertension, dyslipidaemia, diabetes and
obesity.[9,10] Many studies have confirmed that women during
reproductive age with irregular menses/hyperandrogenism/
PCO morphology suffer from severe phenotype and the
greatest number of metabolic risk factors with infertility due to
irregular menses.[11] Studies also suggest that women suffering
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from PCOS are exposed to several psychological problems. It
exerts a negative impact on female identity and contributes to
the deterioration of quality of life. The mental consequences
can be depression and mood disorders.[12,13] In general, women
with PCOS show an increased risk of obstetric, cardiovascular,
metabolic and psychological complications compared to
non-PCOS women.[14] Since PCOS is a complex disorder, for
which multiple treatment approaches are required, depending
on the reason a patient seeks treatment, Clomiphene has
shown the best results in treating infertility, whereas data are
limited regarding the pharmacological treatment of androgenic
symptoms. Long-term consequences of PCOS, which include
type-2 diabetes and cardiovascular disease, can be treated with
anti-diabetic drugs and statins.[15]

and had one full-term normal delivery 5 years ago. Her menses
were regular until her last conception.

Uterine fibroids (UF) are the most frequent gynaecologic
tumour, affecting 70–80% of women in their lifetime. Although
these tumours are benign, they can cause a significant morbidity
and may require invasive treatments, such as myomectomy and
hysterectomy.[16] Both clinical and experimental data suggest
that oestrogen stimulates the growth of UF during reproductive
years.[5,6,17] Studies suggest a positive association between
PCOS and UF.[18]

The per vaginum examination done by a gynaecologist
on 8th August, 2017 revealed anteverted bulky uterus and
clear fornix. Ultrasonography of the pelvis (dated 20th July,
2017) revealed Cervicitis with the presence of endometrial
hyperplasia with an endometrial thickness of 16 mm and
submucosal fibroids. Furthermore, there were multiple,
peripherally arranged follicles suggestive of polycystic ovarian
pathology in both the ovaries [Figure 1]. The patient continued
with the hormonal treatment with no positive outcome and then
visited us for the homoeopathic treatment.

This confirmed case of PCOS with endometrial hyperplasia
and multiple UFs, which has been successfully treated with
homoeopathic intervention.

Patient information

On 13 November 2017, a 26-year-old female presented to the
outpatient department of Regional Research Institute, (H.),
Mumbai, with complaints of irregular menses for the past
3 years. The patient was a graduate, got married 6 years back

History of present complaints

The patient had irregular menses with intermenstrual period of
an average 90–120 days. The duration of bleeding was 7–8 days
with profuse dark red blood. There was an associated severe
backache and pain in the hypogastric region during menses.
After the delivery of her first child, the menses appeared after
20 months. Thereafter, her cycles were delayed, for which she
approached the gynaecologist and started taking hormonal
treatment. The hormonal assay – FSH, LH and prolactin and
thyroid profiles were normal, even though the patient had a
history of galactorrhoea 2 years back. The patient’s spouse
was using a condom as the barrier method of contraception.

Cervicitis was treated with conventional treatment. There was
no past history of any other major illness.

Family history

Mother had early menopause (at age of 30 years) and was
suffering from haemorrhoids. Father was diabetic and
hypertensive.

Figure 1: Ultrasonography – Before treatment
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Physical generals

The patient was fair-complexioned with a moderate build.
Her tongue was white, thick-coated. She was chilly and could
not tolerate cold in general and preferred warmth. She had a
satisfactory appetite and a moderate thirst for small quantities
at small intervals. She had a craving for sweets, chicken and
milk. There was no specific aversion or intolerance to any
specific food item. Her bowel habits were regular with normal
stools. She had profuse perspiration, especially on her head.

Mental generals

The patient was very short-tempered, irritable and obstinate.
She was offended easily, especially after contradiction, and
usually expressed her anger. She had a weeping disposition.
The patient was oversensitive to trifles and desired company.

Particulars

The patient had irregular menses with a cycle of 90–120 days.
There was profuse menstrual bleeding flow for 7–8 days with
severe pain in back and hypogastric region. The last menstrual
period was on 13th September, 2017. There was no complaint
of any abnormal vaginal discharge. The patient had frequent
headaches since 3–4 years, especially after exposure to the sun.
There was no significant finding in her physical examination,
such as pallor.

Analysis of the case and repertorisation

After analysis and evaluation of the symptoms, the totality
of symptoms was constructed and the case was repertorised
with the help of ‘Hompath software – Wildfire’ using complete
repertory [Figure 2].
The following symptoms were considered for repertorisation:
● Angered easily
● Irritability
● Anger especially after contradiction
● Sentimental
● Offended easily
● Weeps easily
● Desire for company
● Obstinate, headstrong
● Cold aggravation
● Desire-Sweets++
● Desires-Chicken+
● Desires-Milk+
● Sun aggravation
● Thirst for small quantities of water at small intervals
● White coated tongue
● Perspiration on head
● Menses irregular
● Menses late
● Menses profuse
● Backache during menses.

Therapeutic intervention, follow-ups and outcomes

On the basis of individualization, Sepia was selected as the
similimum, even though it scored fourth on repertorisation,
covering 19 out of 21 rubrics. On the first visit, Sepia 6C was

Figure 2: Repertorisation sheet

prescribed twice daily to start with, for 15 days, followed by
Sepia 30 for another fortnight. When Sepia did not yield, any
positive result Pulsatilla nigricans was chosen, considering it a
well-known polychrest female remedy. This case, with a wide
spectrum of disturbances related to female reproductive system,
manifested in the form of three pathologies, that is, PCOS, UF
and endometrial hyperplasia, which was considered to be a
suitable case for such a female remedy. As dealing with this case
having multimorbid pathologies had to be treated, Pulsatilla was
chosen with consultation of Materia medica. Therefore, in the
subsequent follow-up, Pulsatilla nigricans 30 was prescribed.
The patient was assessed fortnightly, or as per requirement,
for 14 months. Sulphur 30 was also given as an intercurrent
remedy. A detailed account of follow-ups with prescription is
shown in Table 1, and subsequent improvement was seen in
the USG dated 13 October, 2018 [Figure 3].
The final outcome and possible causal attribution of the
changes in this case were assessed using the ‘Modified Naranjo
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Table 1: Timeline including Follow‑ups
Follow‑up Date
Baseline

Signs and Symptoms

Prescription medicine with
potency and dose

13 November, 2017 Irregular menses since last 3 years
LMP 13 September, 2017
Headache on and off
1
27 November, 2017 Menses not appeared
Headache persistent
2
11 December, 2017 Menses not appeared
Headache persistent
3
04 January, 2018
Menses not appeared
Headache slightly better
4
05 February, 2018 Menses appeared (after 123 days)
LMP‑ 14 January 2018 , Moderate flow
Irritability decreased
Headache slightly better
5
03 March, 2018
Menses not appeared.
Headache occasionally present
6
12 April 2018
Menses appeared. (after 60 days)
LMP‑ 15 March 2018
Profuse flow with backache.
7
26 April, 2018
Menses delayed
Pain in right breast since 8 days.
Tenderness present.
Sleep disturbed since 8 days
8
7 May, 2018
Menses appeared (after 45 days)
LMP – 29 April, 2018
Headache better
Irritability decreased
9
11 June, 2018
Menses delayed
LMP – 29 April, 2018
10
9 July, 2018
Menses appeared (after 41 days)
LMP – 09 June, 2018
11
13 August, 2018
Menses appeared. (after 50 days)
Headache better
LMP – 29 July, 2018
12
10 September, 2018 Menses delayed
LMP – 29 July, 2018
13
15 October, 2018
Menses appeared. (after 53 days)
LMP – 20 September, 2018
Profuse flow. Backache during menses.
Headache persistent. Eruption on tip of fingers with itching since 15 days
USG (13 October, 2018) – Normal sized uterus and ovaries
14
3 November, 2018 Menses appeared (after 39 days)
LMP – 29 October, 2018
Profuse flow
Backache during menses. Eruption on tip of fingers with itching increased since 8 days
15
22 December, 2018 Menses appeared (after 35 days)
LMP – 3 December, 2018
Profuse flow. Backache during menses.
Headache occasionally present.
Eruption on tip of fingers slightly better
16
24 January, 2019
Menses appeared (after 37 days)
LMP‑ 10 January, 2019
Headache relived significantly.
Backache relieved. Eruption on tip of fingers decreased
LMP: Last menstrual period, OD: Once a day, BD: Twice a day
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Sepia 6/BD/15 days

Sepia 30/OD/15 days
Pulsatilla 6/BD/15 days
Pulsatilla 30/OD/15 days
Rubrum/15 days

Pulsatilla 30/OD/15 days
Pulsatilla 30/4 doses
Rubrum/1 month
Pulsatilla 200/6 doses/OD

Rubrum/1 month

Pulsatilla 200/6 doses/OD
Rubrum/1 month
Rubrum/1 month

Pulsatilla 200/8 doses/OD
Pulsatilla 200/6 doses/OD

Pulsatilla 200/single dose
Sulphur 30/2 doses/OD (Given
as antimiasmatic/intercurrent)
Pulsatilla 200/single dose

Rubrum
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criteria’,[19] the total score was 8 [Table 2], which was close
to the maximum score of 13. This shows the positive causal
attribution to the prescribed homoeopathic medicine.
The authors have followed HOM-CASE guidelines for
reporting the outcomes.

Discussion
The conventional treatment in PCOS, though beneficial, is reported
to have side effects after a long use.[20,21] Existing treatments,
including the conventional, have mostly been directed to the
symptoms such as hyperinsulinaemia and hyperandrogenaemia
with resumption of ovulation, but not at the syndrome itself.[22]
Homoeopathy has proven to have an edge in holistic treatment
of the patient. A study undertaken by Central Council for
Research in Homoeopathy at six centres from October 2005 to
September 2009 shows that homoeopathic medicines prescribed
on the basis of totality of symptoms act holistically and show a
positive regulatory influence on female hormones.[23]
Further, a study has shown positive outcomes of the efficacy
of homoeopathy in PCOS. [24] Another study showed a
positive role of homoeopathic therapy in the management of
ovarian cysts with a total resolution of cyst in 16.67% cases
and reduction in the size in 20.83% cases.[25] Effective use
of Calcarea carbonicum and Lycopodium in patients with
basic guiding symptoms for either drug has been found to be
useful for patients with PCOS.[26] Various case reports have
reported large UFs being successfully treated by individualized
homoeopathic treatment.[27,28] A prospective observational
study showed positive results in terms of reduction and
resolution of UFs.[29] Another multicentric randomized clinical
trial conducted on symptomatic UF showed that both LM and
CH potencies were effective in reducing symptoms of UF as
well as effective in improvement of overall health.[30]

Figure 3: Ultrasonography – After treatment

This case illustrates improvement of the patient, both
symptomatically and pathologically. The patient was not on any
other treatment. The prescription had repeated doses all through,
since it was a multimorbid case and the physician felt that such

Table 2: Assessment of outcome with Modified Naranjo Algorithm
Modified Naranjo algorithm
1. Was there an improvement in the main symptom or condition for which the homoeopathic medicine was prescribed?
2. Did the clinical improvement occur within a plausible timeframe relative to the medicine intake?
3. Was there a homeopathic aggravation of symptoms?

Yes

No

Not Sure or N/A

+2

−1

0

+1
+1

−2

0
0

4. Did the effect encompass more than the main symptom or condition, (i.e., were other symptoms not related to the main
presenting complaint, ultimately improved or changed)?
5. Did overall wellbeing improve? (Suggest using a validated scale or mention about changes in physical, emotional and
behavioural elements)
6 (A) Direction of cure: did some symptoms improve in the opposite order of the development of symptoms of the disease?

+1

0
0

+1

0

0

+1

0

0

6 (B) Direction of cure: did at least one of the following aspects apply to the order of improvement of symptoms:
• From organs of more importance to those of less importance
• From deeper to more superficial aspects of the individual
• From the top downwards
7. Did ‘old symptoms’ (defined as non‑seasonal and non‑cyclical symptoms that were previously thought to have
resolved) reappear temporarily during the course of improvement?
8. Are there alternative causes (i.e., other than the medicine) that –with a high probability‑ could have produced the
improvement? (Consider known course of disease, other forms of treatment and other clinically relevant interventions)
9. Was the health improvement confirmed by any objective evidence? (e.g., investigations and clinical examination)

+1

0

0

+1

0

0

−3

+1

0

+2
+1

0

0

0

0

10. Did repeat dosing, if conducted, create similar clinical improvement?
Total score
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a repetition would take care of various symptoms arising from
the combined clinical presentation of various pathologies. Sepia
covered more rubrics than Calc carb, so Sepia was chosen as
the first prescription. After the first prescription of Sepia failed
to get a positive response, Pulsatilla was chosen as the second
prescription, based on the symptom totality. Most of the mental
and physical generals of the case were covered by Pulsatilla
nigricans. It is a well-known polycrest remedy having affinity
to female reproductive organs.[31,32] The case was followed up
for 14 months and symptoms were assessed at each follow-up,
which showed positive outcomes. Ultrasonography was done
after treatment which showed normal findings, that is, normal
endometrial thickness, no hyperechoic or hypoechoic lesions in
the uterus, and no ovarian PCOS morphology. This case depicts
the role of homoeopathic treatment in holistic improvement of
health with PCOS, UF and endometrial hyperplasia being cured,
thus treating the patient as a whole.

Conclusion

The author declares that appropriate patient’s consent has been
obtained for using her images and other clinical information
for reporting in the journal was obtained.
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Syndrome des ovaires polykystiques avec hyperplasie endométriale et fibromes utérins traités par homéopathie - Rapport
de cas.
Introduction: Toute circonstance qui modifie l’équilibre entre les œstrogènes et la progestérone entraîne une stimulation
œstrogénique excessive et prolongée, ou empêche les effets contraires de la progestérone, provoquant ainsi diverses conditions
pathologiques dans le système reproducteur. Les femmes atteintes du SOPK ont le plus souvent des cycles anovulatoires et
de faibles taux sériques de progestérone. L’hyperplasie endométriale est le plus souvent due à un excès d’œstrogènes sans
progestérone. La signification clinique de la sécrétion chronique d’œstrogènes est un risque accru d’hyperplasie endométriale.
Une caractéristique frappante des fibromes utérins est leur dépendance vis-à-vis des œstrogènes et de la progestérone ovariens.
Les traitements existants sont principalement axés sur les symptômes, mais pas sur le syndrome lui-même. Résumé du cas: Une
patiente souffrant de PCOS, avec une hyperplasie de l’endomètre et de multiples fibromes utérins a été traitée avec succès avec
le médicament homéopathique Pulsatilla nigricans. Une nouvelle échographie a montré une épaisseur endométriale normale,
aucune lésion hyperéchogène ou hypoéchogène dans l’utérus et aucune morphologie ovarienne de PCOS après le traitement.
Ainsi, l’utilité des médicaments homéopathiques pour le traitement des pathologies multimorbides liées au système reproducteur
des femmes est démontrée.
Polyzystisches Ovarialsyndrom mit Endometriumhyperplasie und Uterusmyomen, behandelt mit Homöopathie - ein
Fallbericht
Einführung: Jeder Umstand, der das Gleichgewicht von Östrogen und Progesteron stört, führt zu einer übermäßigen, anhaltenden
Östrogenstimulation oder verhindert die entgegenwirkende Wirkung von Progesteron, was verschiedene pathologische Zustände im
Fortpflanzungssystem zur Folge hat. Frauen mit PCOS haben meist anovulatorische Zyklen und niedrige Serumprogesteronspiegel.
Die Endometriumhyperplasie ist meist auf einen Östrogenüberschuss ohne Progesteron zurückzuführen. Die klinische Bedeutung
einer chronischen Östrogensekretion besteht in einem erhöhten Risiko einer Endometriumhyperplasie. Ein auffälliges Merkmal
von Uterusmyomen ist ihre Abhängigkeit vom Östrogen und Progesteron der Eierstöcke. Bestehende Behandlungen sind meist
auf die Symptome, nicht aber auf das Syndrom selbst gerichtet. Zusammenfassung des Falles: Eine an PCOS leidende Patientin
mit Endometriumhyperplasie und multiplen Uterusmyomen wurde erfolgreich mit dem homöopathischen Arzneimittel Pulsatilla
nigricans behandelt. Eine erneute Ultraschalluntersuchung zeigte eine normale Dicke des Endometriums, keine hyperechoischen
oder hypoechoischen Läsionen im Uterus und keine ovarielle PCOS-Morphologie nach der Behandlung. Damit ist die Nützlichkeit
homöopathischer Arzneimittel für die Behandlung multimorbider Pathologien im Zusammenhang mit dem Fortpflanzungssystem
von Frauen nachgewiesen.
पॉलीसिस्टिक गर्भाशय सिंड्रोम के साथ-साथ अंतगर्भाशयकला संबंधी हाइपरप्लासिया तथा गर्भाशय संबंधी गाँठ को होम्योपैथिक
से ठीक किया गया था - एक मामला रिपोर्ट
परिचय: ऐसी कोई भी स्थिति जो एस्ट् रोजन और प्रोजेस्टोरन के संतुलन को बिगाड़ती है वह अत्यधिक, लंबे समय तक चलने वाली एस्ट् रोजेनिक
उत्तेजना, या प्रोजेस्टोरन के प्रतिकारी प्रभावों को रोकने का कारण बनती है जिसके परिणामस्वरूप, प्रजनन तंत्र में कई प्रकार के रोग उत्पन्न
हो जाते हैं । पीसीओएस वाली महिलाओं के अधिकां शतः अनियमित मासिक धर्म एवं सीरम प्रोजेस्टोरन के स्तर न्यून होते हैं । अंतगर्भाशयकला
संबंधी हाइपरप्लासिया रोग अधिकतर प्रायः प्रोजेस्टोरन की अनुपस्थिति में अत्यधिक एस्ट् रोजन की वजह से होता है । क्रॉनिक एस्ट् रोजन स्राव
की नैदानिक महत्वता अंतगर्भाशयकला संबंधी हाइपरप्लासिया रोग का बढ़ता जोखिम है । गर्भाशय गाँ ठ की विचित्र विशेषता यह है कि
वे गर्भाशय के एस्ट् रोजन तथा प्रोजेस्ट्रोन पर आश्रित होते हैं । अधिकां श मौजूदा उपचार सिंड्रोम पर ना होकर लक्षणों को रोकने पर केन्द्रित
हैं । विषय सारांश: एक महिला मरीज़ जो पीसीओएस, के साथ-साथ अंतगर्भाशयकला संबंधी हाइपरप्लासिया तथा अनेक गर्भाशय संबंधी
तनत्वाभों से पीड़ित थी, उसका पल्सेटीला नाइग्रिकेन्स नामक होम्योपैथिक दवा से सफलतापूर्वक उपचार किया गया था। उपचार के बाद
पुनः की गई अल्ट् रासोनोग्राफी ने अंतगर्भाशयकला की मोटाई को सामान्य दिखाया था, गर्भाशय में हाइपरचोइक या हाइपोइकोइक को कोई
नुकसान नही हुआ था तथा गर्भाशय पीसीओएस की बनावट भी सही थी। अतः, महिलाओं के प्रजनन अंग से संबंधित बहु-रोगी विकृतियों के
उपचार में होम्योपैथिक दवाओं की उपयोगिता प्रदर्शित की गई थी।
Síndrome ovárico poliquístico con hiperplasia endometrial y fibromas uterinos tratados con homeopatía - un informe
del caso
Introducción: Cualquier circunstancia que altere el equilibrio del estrógeno y la progesterona conduce a la estimulación
estrogénica excesiva y prolongada, o a la prevención de los efectos contrarrestantes de la progesterona causando diversas
condiciones patológicas en el sistema reproductivo, como resultado. Las mujeres con SOP tienen sobre todo ciclos anovulatorios
y bajos niveles de progesterona sérica. La hiperplasia endometrial se debe con mayor frecuencia al exceso de estrógeno sin
progesterona. La importancia clínica de la secreción crónica de estrógeno es un riesgo creciente de hiperplasia endometrial. Una
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característica llamativa de los fibromas uterinos es su dependencia en el estrógeno ovárico y la progesterona. Los tratamientos
existentes se dirigen principalmente a los síntomas, pero no al síndrome en sí. Resumen del caso: Un paciente que sufría de SOP,
con hiperplasia endometrial y múltiples fibromas uterinos fue tratado exitosamente con el medicamento homeopático Pulsatilla
nigricans. La repetición de la ecografía mostró un grosor endometrial normal, ausencia de lesiones hiperecoicas o hipoecoicas
en el útero y ausencia de morfología ovárica del SOP después del tratamiento. Así, se demuestra la utilidad de los medicamentos
homeopáticos para el tratamiento de patologías multimórbidas relacionadas con el sistema reproductivo de las mujeres.
多囊卵巢综合征伴子宫内膜增生和子宫肌瘤治疗顺势疗法-一例报告

导言:任何改变雌激素和黄体酮平衡的情况都会导致过度，延长的雌激素刺激，或阻止黄体酮的
抵消作用导致生殖系统中的各种病理状况，结果.患有PCOS的女性大多是无排卵周期和低血清黄
体酮水平。子宫内膜增生最常是由于过量的雌激素而没有黄体酮. 慢性雌激素分泌的临床意义是
子宫内膜增生的风险增加.子宫肌瘤的一个显着特征是它们对卵巢雌激素和黄体酮的依赖.现有的
治疗方法主要针对症状，而不是针对综合征本身。 个案摘要: 患有以下疾病的病人PCOS, 子宫
内膜增生和多发性子宫肌瘤用顺势疗法药物白头翁成功治疗.重复超声检查显示子宫内膜厚度正
常, 子宫无高消声或低消声病变，卵巢无 PCOS治疗后的形态. 因此，顺势疗法药物治疗与妇女
生殖系统有关的多病状的有用性得到了证明.
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